I am a medical oncologist with special training in both treating and studying tumors of the head and neck. In my dual role as a clinician-researcher, I care for people with these malignancies and also conduct research aimed at improving their long-term health and survival.
In addition to English, I am fluent in Spanish and Gujarati, a language spoken in Western India.
I joined the Memorial Sloan Kettering faculty in 2011 after a three-year fellowship here. I am deeply honored to work with this distinguished and multidisciplinary group of oncologists, surgeons, radiation oncologists, and scientists — all of whom share the singular goal of improving our treatment options for people with cancers in the oropharynx (throat), mouth, tongue, and other areas of the head and neck.
As a physician with a background in public health, I am particularly interested in the long-term outlook for these patients.
Currently I am working to find answers to two key survivorship issues through two different studies. One is a clinical trial examining the quality of life in long-term survivors of oropharynx cancer that was caused by infection with the sexually transmitted human papillomavirus (HPV).
The other study is a retrospective analysis that uses electronic medical data to help us understand the various causes of mortality in long-term survivors of oropharynx cancer. The aim is to identify early at-risk activities in these survivors. How can we help influence behavior and address any medical issues involved so that these individuals can live longer?
Outside of Memorial Sloan Kettering, I have been a member of the American Society of Clinical Oncology (ASCO) since 2007.
- Clinical Expertise: Cancer Survivorship
- Languages Spoken: English; Spanish
- Education: MD, University of Illinois College of Medicine; MPH, University of Illinois School of Public Health
- Residencies: New York University/Bellevue Hospital
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Internal Medicine, Medical Oncology
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Shrujal S. Baxi
- A Phase I/II Study of Nivolumab Immunotherapy Given Before Surgery for Merkel Cell or Head and Neck Cancers
- A Phase III Study of MEDI4736 with and without Tremelimumab versus Standard of Care in Recurrent/Metastatic Head and Neck Cancer
- Assessment of a Survivorship Tool for People Previously Treated for Head and Neck Cancers
Clinical Trials Co-Investigated by Shrujal S. Baxi
- A Phase I Study of BYL719 Given with Cetuximab and Radiation Therapy in Patients with Stage III/IVB Head and Neck Cancer
- A Phase I/II Study of BYL719 plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Cancer
- A Pilot Study of Ribavirin to Treat Recurrent or Metastatic HPV-Related Cancers
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more